Pregnancy
Swedish company develops reusable pregnancy test

The femtech company Pharmista Technologies is developing an eco-friendly pregnancy test, after being admitted to the SmiLe’s incubator program.
The pregnancy test is the most widely used home diagnostic test in the world. Alice Mattsson, business developer, and her co-founder, Robert Porter, a researcher and entrepreneur, are developing a pregnancy test that can be easily and hygienically reused.
Customers just need to buy a monitor that contains chemical substances and electronics. Replaceable paper strips are loaded into the monitor before each test and the results appear on a display that provides a simpler reading than currently available tests.
The paper strips do not contain environmentally hazardous substances and are made of cellulose that is easily biodegradable which makes the product eco-friendly.
An initial prototype of the pregnancy test is expected to be ready as soon as this autumn, after which the company plans to raise more capital.
Mattsson’s business concept received considerable attention, most notably two years ago when the co-founder was one of the entrepreneurs who won the Best Business Idea of the Year in the 2020 Venture Cup.
Last year, she participated in the entrepreneurship program SmiLe HealthTech Bootcamp. She has now further developed the company and meets the criteria for admission to the incubator program.
“It feels great to be accepted to SmiLe’s incubator program and become part of the SmiLe community,” Mattsson says.
“When I was ready to apply to an incubator, SmiLe was my first choice and here, I can get support in those areas where I lack personal experience and competence, such as patents and regulatory aspects.”
Lina Boreson, chief operating officer for SmiLe Incubator, is happy to support Alice in the development of the company.
“She is one of many talented young entrepreneurs who apply to SmiLe with innovations that will solve some of today’s problems in the health area, while also pursuing a clear sustainability profile.”
Pharmista’s group of external advisors also includes Dr. Christina Östberg Lloyd, a gynecologist with extensive experience in the life science industry and CEO of the femtech company Pharmiva, Börje Sellergren, professor of biomedical technology at Malmö University in Sweden and Erika Toft, innovation adviser at Malmö University.
To find out more, visit pharmistatechnologies.com.
Pregnancy
Women with multiple long-term conditions face increased pregnancy risks – study

Women entering pregnancy with multiple conditions face a 20 per cent higher miscarriage risk and around four times the risk of anxiety and depression, new research has revealed.
The observational study found women with two or more pre-existing long-term physical or mental health conditions also had a 69 per cent higher risk of severe nausea and vomiting.
They had more than double the risk of venous thromboembolism, when a blood clot forms inside a vein, and a 42 per cent higher risk of pre-eclampsia, a pregnancy complication involving high blood pressure.
Dr Steven Wambua, research fellow in health data science at King’s College London and joint first author, said: “Maternity care is still largely organised around single health conditions, but one in five women now enters pregnancy with two or more.
“By harmonising five datasets covering all four UK nations, we could show consistently and across a much broader range of outcomes than before, that these women face higher risks and that risk climbs with every additional condition.”
Researchers from King’s College London, Queen’s University Belfast, Bristol NHS Foundation Trust, the University of Birmingham, Swansea University and the University of St Andrews analysed more than 2.2m pregnancies and birth events recorded between 2000 and 2022.
The data came from five datasets covering England, Scotland, Wales and Northern Ireland.
Around one in five pregnant women in the UK live with multiple long-term conditions, but their combined impact on pregnancy is poorly understood.
The study found risks rose with each additional condition. Women with three or more conditions had more than three-and-a-half times the risk of venous thromboembolism compared with women without long-term health conditions.
Women with multiple conditions also had a 32 per cent higher risk of placental abruption, when the placenta separates from the womb before birth, and a 26 per cent higher risk of gestational diabetes.
The researchers said maternity care pathways vary considerably and, where they exist, are often organised around individual conditions.
They said the findings highlight a need to restructure these pathways to address the complex needs of women living with multiple conditions.
Professor Krishnarajah Nirantharakumar, clinical professor of public health and health data science at King’s College London, MuM-PreDiCT principal investigator and joint senior author, said: “These findings make a strong case for recognising multiple long-term conditions as a marker of antenatal risk in its own right.
“That means identifying these women at maternity booking, assessing physical and mental health needs together, and joining up obstetric, primary care and mental health services around them.
“The near four-fold risk of antenatal anxiety and depression is particularly striking, and points to perinatal mental health support as an urgent priority.
Dr Kelly-Ann Eastwood of Bristol NHS Foundation Trust and Queen’s University Belfast, joint senior author, added: “Our results help define the urgent clinical challenges facing both women entering pregnancy with multiple long-term conditions, and clinicians caring for them across the UK.
“Supporting recommendations from recent national maternity and neonatal investigation reports, there is a critical need to address healthcare inequalities, and improve support for women with pre-existing mental health conditions.
“These findings highlight the pressing need to restructure existing maternity services to improve antenatal outcomes.
The authors cautioned that, because the study used routinely collected health records, some conditions and outcomes may have been under-recorded or recorded inconsistently.
Further work by the MuM-PReDiCT consortium will examine birth and child outcomes and identify which combinations of long-term conditions carry the greatest risk.
Pregnancy
Climbing during pregnancy may be safer than long assumed, study finds

Climbing during the third trimester was not linked to higher rates of self-reported pregnancy complications in a global study.
The findings provide direct evidence on an activity pregnant women have traditionally been advised to avoid because of concerns about falls.
Researchers surveyed 692 people about climbing during pregnancy, falls, maternal and baby health outcomes and their return to the activity after giving birth.
The study recorded almost 64,000 hours of climbing among participants.
During that time, participants reported 155 “hard falls”, defined as falls or catches forceful enough to be remembered or cause concern.
The rate of adverse clinical events, meaning negative medical outcomes affecting the pregnancy or baby, was 0.03 per 1,000 hours of climbing exposure. All babies in the study were born live.
Researchers found no significant difference in pregnancy or foetal health outcomes between participants who stopped climbing at or before 27 weeks and those who continued beyond that point.
The findings suggest continuing the activity into the third trimester was not associated with increased self-reported complications among those surveyed.
The survey also found 96 per cent of participants said that, despite concerns about climbing while pregnant, they felt “happy” or “very happy” that they had continued.
Margie Davenport, professor in the Faculty of Kinesiology, Sport, and Recreation and lead author of the study, said the preliminary findings challenge an assumption about maternal exercise that had been based on opinion rather than research.
She said: “For decades we have restricted pregnant women from activities like climbing due to concern for their health and the health of the baby, but our evidence suggests it’s beneficial for both mental and physical health.”
Entrepreneur
Peripear wins Innovate UK Women in Innovation Award

Medtech startup Peripear has won an Innovate UK award for developing a wearable designed to prevent perineal trauma during childbirth.
The Oxford-based company is developing a hands-free warm compress device for use on the perineum during the second stage of labour.
Peripear describes its product as the world’s first automated perineal thermotherapy wearable, designed to prevent perineal trauma during childbirth.
The device is intended to reduce severe tearing and episiotomies while improving maternal comfort.
Peripear has secured an Innovate UK Women in Innovation Award and a £74,974 grant.
The funding will support further product development ahead of the company’s planned first-in-human study.
Nina van Schaick, co-founder and chief operating officer of Peripear and midwife, said: “I’m sure I wasn’t the only one to see this gap.
“I was incredibly lucky to meet my co-founder, Eviatar Natan, right as my frustration about the lack of translation of evidence into practice had peaked.
“There was a proven mechanism that could reduce injuries occurring in up to 90 per cent of vaginal births, and it was being left out of clinical pathways simply because no standardised tool existed to deliver it.
“I’m a farmer’s granddaughter, and when I started practising over 14 years ago, I asked: where is the tool I need to implement this evidence? I looked around and realised we were still asking clinicians to improvise.
“Peripear is what happens when the person who has lived the problem, both personally and professionally, meets the person who can help her build the solution.”
Entrepreneur2 weeks agoApplications close August 18 for Women’s Health Innovation Summit 2026 Innovation Showcase
Menopause2 weeks agoThird of women unaware of perimenopause mental health impact
Fertility6 days agoChelsea FC Women to launch first-of-its-kind player fertility fund
Entrepreneur2 weeks agoWomen’s Health Week Europe 2026 releases fully populated agenda ahead of October summit
Menopause1 week agoMenopausal hormone therapy may lower dementia risk, study suggests
Hormonal health2 weeks agoWe are wrapping our children in plastic and calling it care
Diagnosis2 weeks agoChemicals in plastics may be linked to high blood pressure during pregnancy
News2 weeks agoWomen with endometriosis face 46% higher risk of type 2 diabetes – study













31 Comments